Published in Environ Health Perspect on April 01, 1998
Quantitative comparisons of in vitro assays for estrogenic activities. Environ Health Perspect (2000) 1.49
Cross-species and interassay comparisons of phytoestrogen action. Environ Health Perspect (2001) 1.29
Enhanced degradation of an endocrine-disrupting chemical, butyl benzyl phthalate, by Fusarium oxysporum f. sp. pisi cutinase. Appl Environ Microbiol (2002) 0.90
Phytoestrogen signaling and symbiotic gene activation are disrupted by endocrine-disrupting chemicals. Environ Health Perspect (2004) 0.86
Characterization of estrogen and androgen activity of food contact materials by different in vitro bioassays (YES, YAS, ERα and AR CALUX) and chromatographic analysis (GC-MS, HPLC-MS). PLoS One (2014) 0.82
Comparison of the short term toxicity of phthalate diesters and monoesters in sprague-dawley male rats. Toxicol Res (2010) 0.82
Computational model of steroidogenesis in human H295R cells to predict biochemical response to endocrine-active chemicals: model development for metyrapone. Environ Health Perspect (2010) 0.80
Chemicals having estrogenic activity can be released from some bisphenol A-free, hard and clear, thermoplastic resins. Environ Health (2014) 0.78
Fluorene-9-bisphenol is anti-oestrogenic and may cause adverse pregnancy outcomes in mice. Nat Commun (2017) 0.75
Species, interindividual, and tissue specificity in endocrine signaling. Environ Health Perspect (1999) 0.75
The nuclear receptor superfamily: the second decade. Cell (1995) 24.99
Evidence for decreasing quality of semen during past 50 years. BMJ (1992) 17.44
Are oestrogens involved in falling sperm counts and disorders of the male reproductive tract? Lancet (1993) 12.83
Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women. N Engl J Med (1971) 11.95
Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci U S A (1996) 10.94
Developmental effects of endocrine-disrupting chemicals in wildlife and humans. Environ Health Perspect (1993) 10.04
Blood levels of organochlorine residues and risk of breast cancer. J Natl Cancer Inst (1993) 8.11
An oxysterol signalling pathway mediated by the nuclear receptor LXR alpha. Nature (1996) 7.86
Persistent DDT metabolite p,p'-DDE is a potent androgen receptor antagonist. Nature (1995) 6.33
Bisphenol-A: an estrogenic substance is released from polycarbonate flasks during autoclaving. Endocrinology (1993) 6.20
The E-SCREEN assay as a tool to identify estrogens: an update on estrogenic environmental pollutants. Environ Health Perspect (1995) 5.37
Environmentally persistent alkylphenolic compounds are estrogenic. Endocrinology (1994) 4.10
A variety of environmentally persistent chemicals, including some phthalate plasticizers, are weakly estrogenic. Environ Health Perspect (1995) 3.47
Soy intake and cancer risk: a review of the in vitro and in vivo data. Nutr Cancer (1994) 3.38
Medical hypothesis: xenoestrogens as preventable causes of breast cancer. Environ Health Perspect (1993) 3.07
Estrogens as a cause of human cancer: the Richard and Hinda Rosenthal Foundation award lecture. Cancer Res (1988) 2.90
Semen analyses in 1,283 men from the United States over a 25-year period: no decline in quality. Fertil Steril (1996) 2.52
Phytoestrogen interaction with estrogen receptors in human breast cancer cells. Endocrinology (1978) 2.42
Testicular cancer in nine northern European countries. Int J Cancer (1994) 2.32
The search for the causes of breast and colon cancer. Nature (1989) 2.25
Activation of the human androgen receptor through a protein kinase A signaling pathway. J Biol Chem (1996) 2.15
Pesticides and polychlorinated biphenyl residues in human breast lipids and their relation to breast cancer. Arch Environ Health (1992) 2.10
Membrane estrogen receptors identified by multiple antibody labeling and impeded-ligand binding. FASEB J (1995) 2.03
Reproductive tract lesions in male mice exposed prenatally to diethylstilbestrol. Science (1975) 2.00
Coupling of dual signaling pathways: epidermal growth factor action involves the estrogen receptor. Proc Natl Acad Sci U S A (1992) 1.98
The nuclear receptor steroidogenic factor 1 acts at multiple levels of the reproductive axis. Genes Dev (1994) 1.97
Data from men in greater Seattle area reveals no downward trend in semen quality: further evidence that deterioration of semen quality is not geographically uniform. Fertil Steril (1996) 1.93
Estrogenic and antiestrogenic actions of PCBs in the female rat: in vitro and in vivo studies. Reprod Toxicol (1993) 1.89
Geographic variations in sperm counts: a potential cause of bias in studies of semen quality. Fertil Steril (1996) 1.85
Environmental and dietary estrogens and human health: is there a problem? Environ Health Perspect (1995) 1.79
The prostate: an increasing medical problem. Prostate (1990) 1.67
Commonly occurring plant flavonoids have estrogenic activity. Mol Pharmacol (1993) 1.67
Maternal and gestational factors affecting the risk of cryptorchidism and inguinal hernia. Int J Epidemiol (1984) 1.60
Reproductive biology. Another DDT connection. Nature (1995) 1.56
Structure-dependent, competitive interaction of hydroxy-polychlorobiphenyls, -dibenzo-p-dioxins and -dibenzofurans with human transthyretin. Chem Biol Interact (1993) 1.52
Survey and assessment of mammalian estrogen biological assays for hazard characterization. Fundam Appl Toxicol (1996) 1.47
Convergent pathways for steroid hormone- and neurotransmitter-induced rat sexual behavior. Science (1994) 1.46
Endocrine treatment of breast cancer in women. Endocr Rev (1990) 1.44
Diverging trends in incidence and mortality of testicular cancer in Denmark, 1943-1982. Br J Cancer (1986) 1.44
A yeast estrogen screen for examining the relative exposure of cells to natural and xenoestrogens. Environ Health Perspect (1996) 1.40
Organochlorine compounds in relation to breast cancer, endometrial cancer, and endometriosis: an assessment of the biological and epidemiological evidence. Crit Rev Toxicol (1995) 1.35
The epidemiology of cryptorchidism. John Radcliffe Hospital Cryptorchidism Research Group. Horm Res (1988) 1.33
Modulation of gene expression and endocrine response pathways by 2,3,7,8-tetrachlorodibenzo-p-dioxin and related compounds. Pharmacol Ther (1995) 1.30
Environmental estrogenic effects of alkylphenol ethoxylates. Crit Rev Toxicol (1996) 1.26
The functions of corticosteroid-binding globulin and sex hormone-binding globulin: recent advances. Endocr Rev (1990) 1.26
Antiestrogenic activity of hydroxylated polychlorinated biphenyl congeners identified in human serum. Toxicol Appl Pharmacol (1997) 1.24
Testicular cancer. Cancer Surv (1994) 1.24
Fertility in men exposed prenatally to diethylstilbestrol. N Engl J Med (1995) 1.22
Binding properties of androgen receptors. Evidence for identical receptors in rat testis, epididymis, and prostate. J Biol Chem (1976) 1.20
Molecular properties of corticosteroid binding globulin and the sex-steroid binding proteins. Endocr Rev (1990) 1.13
Increased incidence of germ cell testicular cancer in New Zealand Maoris. Br J Cancer (1992) 1.12
Estradiol causes the rapid accumulation of cAMP in human prostate. Proc Natl Acad Sci U S A (1994) 1.11
A versatile method for the determination of serum cortisol binding globulin and sex hormone binding globulin binding capacities. Clin Chim Acta (1983) 1.10
The peroxisome proliferator-activated receptor alpha is a phosphoprotein: regulation by insulin. Endocrinology (1996) 1.10
Prenatal exposure to diethylstilbestrol in mice: toxicological studies. J Toxicol Environ Health (1977) 1.09
National Cancer Institute roundtable on prostate cancer: future research directions. Cancer Res (1991) 1.09
The other estrogen receptor in the plasma membrane: implications for the actions of environmental estrogens. Environ Health Perspect (1995) 1.09
The human testis--an organ at risk? Int J Androl (1992) 1.08
Steroidogenic factor 1 is the essential transcript of the mouse Ftz-F1 gene. Mol Endocrinol (1995) 1.08
Failure of chloro-S-triazine-derived compounds to induce estrogen receptor-mediated responses in vivo and in vitro. Fundam Appl Toxicol (1996) 1.06
Steroidogenic assessment using ovary culture in cycling rats: effects of bis(2-diethylhexyl)phthalate on ovarian steroid production. Reprod Toxicol (1993) 1.05
Rising incidence of breast cancer: relationship to stage and receptor status. J Natl Cancer Inst (1990) 1.05
Long-term effects of perinatal exposure to sex steroids and diethylstilbestrol on the reproductive system of male mammals. Int Rev Cytol (1983) 1.04
The binding properties of pyrethroids to human skin fibroblast androgen receptors and to sex hormone binding globulin. J Steroid Biochem (1990) 1.02
Estrogenic activities of chlorinated hydrocarbons. J Toxicol Environ Health (1978) 1.01
Comparative effectiveness of estrogens on fluid imbibition and growth of the rat's uterus. Endocrinology (1959) 1.00
Excretion of the lignans enterolactone and enterodiol and of equol in omnivorous and vegetarian postmenopausal women and in women with breast cancer. Lancet (1982) 1.00
Soybeans inhibit mammary tumors in models of breast cancer. Prog Clin Biol Res (1990) 0.99
Biological effects of sex hormone-binding globulin on androgen-induced proliferation and androgen metabolism in LNCaP prostate cells. Endocrinology (1991) 0.99
Surprising places of estrogenic activity. Endocrinology (1993) 0.99
The control of the interaction of sex hormone-binding globulin with its receptor by steroid hormones. J Biol Chem (1990) 0.99
Birth order and risk of testicular cancer. Cancer Causes Control (1992) 0.98
Biologically active steroids activate receptor-bound human sex hormone-binding globulin to cause LNCaP cells to accumulate adenosine 3',5'-monophosphate. J Clin Endocrinol Metab (1990) 0.98
Testosterone-estradiol-binding globulin binds to human prostatic cell membranes. Biochem Biophys Res Commun (1985) 0.98
Incidence and descriptive features of testicular cancer among United States whites, blacks, and Hispanics, 1973-1982. Cancer (1986) 0.95
Estrogen-stimulation of postconfluent cell accumulation and foci formation of human MCF-7 breast cancer cells. J Cell Biochem (1991) 0.94
Diethylstilbestrol and other estrogens in the environment. Fundam Appl Toxicol (1984) 0.93
Bioassay of estrogens using the mouse uterine response. Endocrinology (1951) 0.92
Kepone, mirex, dieldrin, and aldrin: estrogenic activity and the induction of persistent vaginal estrus and anovulation in rats following neonatal treatment. Environ Res (1978) 0.92
Solubilization and partial characterization of the sex hormone-binding globulin receptor from human prostate. J Biol Chem (1989) 0.91
Stimulation of prostate cancer growth by androgens and estrogens through the intermediacy of sex hormone-binding globulin. Endocrinology (1996) 0.91
Techniques for detection of estrogenicity. Environ Health Perspect (1995) 0.87
Endocrine treatment for breast cancers: biological rationale and current progress. J Steroid Biochem Mol Biol (1990) 0.86
The mitogenic action of oestrogens in the vaginal epithelium of the ovariectomized mouse. J Endocrinol (1960) 0.86
ENDOCRINE PROPERTIES AND LONG-TERM SAFETY OF ORAL CONTRACEPTIVES. Metabolism (1965) 0.86
The Allen-Doisy test for estrogens reinvestigated. Steroids (1971) 0.85
A recognition system for sex-hormone-binding protein-estradiol complex in human decidual endometrium plasma membranes. Biochim Biophys Acta (1984) 0.84
Specific steroid-binding glycoproteins of human blood plasma: novel data on their structure and function. J Steroid Biochem (1990) 0.83
Optimization of estrogen growth response in MCF-7 cells. In Vitro Cell Dev Biol (1992) 0.83
Estrogen assays using the rat uterus. Endocrinology (1954) 0.80
Sex steroid-binding protein interacts with a specific receptor on human premenopausal endometrium membrane: modulating effect of estradiol. Steroids (1991) 0.79
Assessing the estrogenic and dioxin-like activities of chemicals and complex mixtures using in vitro recombinant receptor-reporter gene assays. Can J Physiol Pharmacol (1996) 0.79
Effects of ethane dimethanesulfonate (EDS) on adult and immature rabbit Leydig cells: comparison with EDS-treated rat Leydig cells. Biol Reprod (1994) 0.78
Biological relevance of the interaction between sex steroid binding protein and its specific receptor of MCF-7 cells: effect on the estradiol-induced cell proliferation. J Steroid Biochem Mol Biol (1993) 0.78
Receptor-mediated endocytosis of an extracellular steroid-binding protein (TeBG) in MCF-7 human breast cancer cells. Endocrinology (1991) 0.78
Antiproliferative activity of mammalian lignan derivatives against the human breast carcinoma cell line, ZR-75-1. Cancer Invest (1990) 0.78
The effects of various steroids on the vaginal histology in the rat. Fertil Steril (1973) 0.77
Breast cancer incidence is on the rise--but why? J Natl Cancer Inst (1990) 0.76
The receptor for human sex steroid binding protein (SBP) is expressed on membranes of neoplastic endometrium. J Steroid Biochem Mol Biol (1992) 0.76